Radka Fahey

Principal Investigator - GlycoScience Group

Biography

Radka Fahey (Saldova) is an independent investigator with more than 16 years of experience in glycobiology; glycobiomarker discovery, glycosylation epigenetics, the role of glycosylation in disease and on therapeutics, and the development of high-throughput technologies for glycan analysis.

Dr Fahey joined the GlycoScience group in May 2005 at University of Oxford (PI Prof Pauline M Rudd) as a Research Assistant, moved to NIBRT with the group in September 2006 and defended her PhD at The University of Chemistry and Technology, Prague, in November 2007. She continued as a Postdoctoral Researcher working on cancer glycobiomarkers and glycan analysis. Dr Fahey has been awarded an SFI Starting Investigator research grant (SIRG) for “Epigenetic regulation of glycosylation and the impact on chemoresistance in cancer” which commenced in October 2014 and concluded in March 2019.

Since then, she has expanded the funding and projects on the role of glycomics in other diseases, as well as linking them with other “omics” platforms to attempt not only to diagnose but also better understand disease pathologies. She has published over 87 peer-reviewed publications and presented at over 100 national and international conferences and collaborative meetings.

 

Radka-Fahey

Radka Fahey

Principal Investigator - GlycoScience Group

radka.fahey@nibrt.ie